147 related articles for article (PubMed ID: 38326481)
41. High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma.
Gu Y; Yuan YH; Xu J; Shi QL; Qu XY; Guo R; Bai H; Xu JD; Li JY; Chen LJ
Oncotarget; 2017 Jul; 8(29):48350-48361. PubMed ID: 28418851
[TBL] [Abstract][Full Text] [Related]
42. Semi-quantitative FDG parameters predict survival in multiple myeloma patients without autologous stem cell transplantation.
Lee H; Hyun SH; Cho YS; Moon SH; Choi JY; Kim K; Lee KH
Cancer Imaging; 2023 Oct; 23(1):104. PubMed ID: 37891633
[TBL] [Abstract][Full Text] [Related]
43. Automatic digital quantification of bone marrow myeloma volume in appendicular skeletons - clinical implications and prognostic significance.
Nishida Y; Kimura S; Mizobe H; Yamamichi J; Kojima K; Kawaguchi A; Fujisawa M; Matsue K
Sci Rep; 2017 Oct; 7(1):12885. PubMed ID: 29018236
[TBL] [Abstract][Full Text] [Related]
44. A prognostication system based on clinical parameters and [
Li J; Zhang X; Qin C; Sun X; Xu X; Cao G; Gai Y; Sun C; Hu Y; Lan X
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1665-1670. PubMed ID: 36576511
[TBL] [Abstract][Full Text] [Related]
45. The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR).
Bergin K; Wellard C; Moore E; McQuilten Z; Blacklock H; Harrison SJ; Ho PJ; King T; Quach H; Mollee P; Walker P; Wood E; Spencer A;
Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e510-e520. PubMed ID: 33785297
[TBL] [Abstract][Full Text] [Related]
46. [Outcomes of lenalidomide-based treatment for 57 patients of relapsed or refractory multiple myeloma].
Deng SH; Xu Y; Sui WW; An G; Mao XH; Li ZJ; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):487-493. PubMed ID: 28655091
[No Abstract] [Full Text] [Related]
47. Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.
Dong H; Huang W; Ji X; Huang L; Zou D; Hao M; Deng S; Shen Z; Lu X; Wang J; Song Z; Zhang X; Xue H; Xia S
AJR Am J Roentgenol; 2022 Feb; 218(2):310-319. PubMed ID: 34523949
[No Abstract] [Full Text] [Related]
48. Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology.
Mai EK; Hielscher T; Kloth JK; Merz M; Shah S; Hillengass M; Wagner B; Hose D; Raab MS; Jauch A; Delorme S; Goldschmidt H; Weber MA; Hillengass J
Eur Radiol; 2016 Nov; 26(11):3939-3948. PubMed ID: 26767378
[TBL] [Abstract][Full Text] [Related]
49. Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis.
Li Q; Ai L; Zuo L; Li J; Zhao F; Xu A; Zhang B; Cai L; Hu Y; Sun C
Ann Med; 2024 Dec; 56(1):2338604. PubMed ID: 38599340
[TBL] [Abstract][Full Text] [Related]
50. [Clinical Significance of CD28 Expression in Newly Diagnosed Multiple Myeloma].
Zhang PP; Li JJ; Hu ZL; Zhu JF; Wang M; Zhang F; Li BZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1785-1790. PubMed ID: 36476904
[TBL] [Abstract][Full Text] [Related]
51. Dynamic contrast-enhanced magnetic resonance imaging parameters correlate with advanced revised-ISS and angiopoietin-1/angiopoietin-2 ratio in patients with multiple myeloma.
Terpos E; Matsaridis D; Koutoulidis V; Zagouri F; Christoulas D; Fontara S; Panourgias E; Gavriatopoulou M; Kastritis E; Dimopoulos MA; Moulopoulos LA
Ann Hematol; 2017 Oct; 96(10):1707-1714. PubMed ID: 28766001
[TBL] [Abstract][Full Text] [Related]
52. Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study.
Goldsmith SR; Fiala MA; Dukeman J; Ghobadi A; Stockerl-Goldstein K; Schroeder MA; Tomasson M; Wildes TM; Vij R
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):285-289. PubMed ID: 30792096
[TBL] [Abstract][Full Text] [Related]
53. Assessment of Total Lesion Glycolysis by
McDonald JE; Kessler MM; Gardner MW; Buros AF; Ntambi JA; Waheed S; van Rhee F; Zangari M; Heuck CJ; Petty N; Schinke C; Thanendrarajan S; Mitchell A; Hoering A; Barlogie B; Morgan GJ; Davies FE
Clin Cancer Res; 2017 Apr; 23(8):1981-1987. PubMed ID: 27698001
[No Abstract] [Full Text] [Related]
54. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Significance Of The Inflammatory Index-Based Scoring System In Patients Preliminarily Diagnosed With Multiple Myeloma In The Bortezomib-Based Chemotherapy Era.
Liu S; Shi J; Guo H; Xu F; Wei M; Sun K; Chen Y
Cancer Manag Res; 2019; 11():9409-9420. PubMed ID: 31807070
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of semi-quantitative parameters of
Wan B; Zhang S; Wang P; Deng P; Dai W
Ann Nucl Med; 2023 Mar; 37(3):155-165. PubMed ID: 36528697
[TBL] [Abstract][Full Text] [Related]
57. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
[TBL] [Abstract][Full Text] [Related]
58. Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities.
Jia S; Bi L; Chu Y; Liu X; Feng J; Xu L; Zhang T; Gu H; Yang L; Bai Q; Liang R; Tian B; Gao Y; Tang H; Gao G
Front Oncol; 2022; 12():805702. PubMed ID: 35372057
[TBL] [Abstract][Full Text] [Related]
59. Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
Alzahrani K; Pasvolsky O; Wang Z; Milton DR; Tanner MR; Bashir Q; Srour S; Saini N; Lin P; Ramdial J; Nieto Y; Lee HC; Patel KK; Manasanch EE; Kebriaei P; Thomas SK; Weber DM; Orlowski RZ; Shpall EJ; Champlin R; Qazilbash MH
Br J Haematol; 2024 May; 204(5):1944-1952. PubMed ID: 38448009
[TBL] [Abstract][Full Text] [Related]
60. The prognostic value of the controlling nutritional status score in patients with multiple myeloma.
Kamiya T; Ito C; Fujita Y; Ogura S; Mizuno K; Sakurai A; Aisa Y; Nakazato T
Leuk Lymphoma; 2020 Aug; 61(8):1894-1900. PubMed ID: 32306801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
